Examples of using Expected to prescribe in English and their translations into Finnish
{-}
-
Colloquial
-
Official
-
Medicine
-
Financial
-
Ecclesiastic
-
Official/political
-
Computer
-
Programming
The Marketing Authorisation Holder shall ensure that all physicians who are expected to prescribe YERVOY are provided with the following.
The company that makes Victrelis will ensure that all doctors expected to prescribe the medicine are provided with an educational pack with detailed information on the medicine, including information on the risk of anaemia and other side effects.
The MAH shall provide an educational pack targeting all physicians who are expected to prescribe/use Pioglitazone.
The MAH shall ensure that at launch all physicians expected to prescribe the product are provided with information on the correct and safe use of the product.
The company that markets Vyndaqel will provide educational material to all doctors expected to prescribe Vyndaqel.
The MAH must ensure that at launch all physicians who are expected to prescribe Esbriet are provided with a physician information pack containing the following.
The MAH shall provide an educational pack prior to launch, targeting all physicians who are expected to prescribe/use Eliquis.
The MAH should aim to provide all HCPs who are are expected to prescribe Ruconest with the educational pack within one month after approval by the NCA.
The MAH shall provide an educational pack targeting all physicians who are expected to prescribe/use Pioglitazone.
The MAH shall ensure that, all physicians,pharmacists and patients expected to prescribe/dispense/use Instanyl are provided with educational material regarding the correct and safe use of the product.
The MAH shall provide an educational pack prior to launch targeting all physicians who are expected to prescribe/use lomitapide.
The Marketing Authorisation Holder shall ensure that all physicians who are expected to prescribe or use Eurartesim are provided with a healthcare profession educational pack containing the following.
The MAH shall provide an educational pack for each therapeutic indication,targeting all physicians who are expected to prescribe/use Pradaxa.
The MAH shall ensure that all healthcare professionals who are expected to prescribe or use Provenge are provided with the following items.
In addition, the company that markets Kolbam will provide educational material with information on the correct and safe use of Kolbam to all doctors expected to prescribe this medicine.
The MAH shall continuously ensure that all physicians who are expected to prescribe Odomzo are provided with the following.
The MAH shall ensure that all physicians who are expected to prescribe/use Xiapex are appropriately trained in the correct administration of the medicinal product and experienced in the diagnosis and management of Dupuytren's contracture and Peyronie's disease.
The Marketing Authorisation Holder shall ensure that all physicians who are expected to prescribe/use Cubicin are provided with.
The company that markets Atripla will ensure that all doctors expected to prescribe the medicine are provided with an educational pack that includes information on the increased risk of kidney disease with tenofovir disoproxil-containing medicines such as Atripla.
The MAH shall provide an educational pack targeting all physicians who are expected to prescribe PROCYSBI prior to the launch.
The company that makes Bronchitol must ensure that all healthcare professionals expected to prescribe the medicine are provided with important safety information including information on the risk of narrowing of the airways in the lungs and the coughing of blood and how to manage this risk.
The Marketing Authorisation Holder(MAH) should ensure that all healthcare professionals who are expected to prescribe Cinryze are provided with an Educational pack.
The company that makes Enbrel will provide educational material for doctors expected to prescribe the product(to teach patients how to use the pre-filled pen correctly) and for patients so they can recognise any serious side effects, and know when to seek urgent attention from their doctor.
The MAH shall provide an educationalpack prior to launch, targeting all physicians who are expected to prescribe/use Xarelto.
The MAH shall ensure that, at launch, all physicians,pharmacists and patients expected to prescribe/use PecFent are provided with educational material informing about the correct and safe use of the product.
The Marketing Authorisation Holder(MAH) shall conduct an educational programme to ensure that all physicians who are expected to prescribe/use Inflectra are aware of.
In addition, the company that makes Yervoy must ensure that all healthcare professionals expected to prescribe the medicine as well as patients are provided with a brochure with safety information on the medicine including the side effects related to the excessive activity of the immune system.
The Marketing Authorisation Holder(MAH) should ensure that all Healthcare Professionals who are expected to prescribe Daliresp are provided with an updated Educational pack.
The company that markets Eurartesim will provide all doctors expected to prescribe or use Eurartesim with an educational pack containing important information on the correct use of the medicine, including a checklist of the medicines that Eurartesim must not be given with, to reduce the risk of QTc interval prolongation.
The MAH shall continuously ensure that all physicians who are expected to prescribe Erivedge are provided with the following.